VU6010608, a Novel mGlu<sub>7</sub> NAM from a Series of <i>N</i>-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides

Carson W. Reed, Kevin McGowan, Paul K. Spearing, Branden J. Stansley, Hanna F. Roenfanz, Darren W. Engers, Alice L. Rodriguez, Eileen M. Engelberg, Vincent B. Luscombe, Matthew T. Loch,

ACS Medicinal Chemistry Letters · 2017 · 24 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

Herein, we report the structure–activity relationships within a series of mGlu 7 NAMs based on an N -(2-(1 H -1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamide core with excellent CNS penetration ( K p 1.9–5.8 and K p,uu 0.4–1.4). Analogues in this series displayed steep SAR. Of these, VU6010608 ( 11a ) emerged with robust efficacy in blocking high frequency stimulated long-term potentiation in electrophysiology studies.

References

19